Evernorth Research Institute
Actionable intelligence for better care.
There’s truth in health care data.
At the Evernorth Research Institute, we analyze anonymized, patient-level clinical and administrative data, and industry data to unlock intelligence that prompts action—troubling trends and potential challenges that may affect your beneficiaries and your business, and what to do about them.
Our work leverages large and robust data sets, enabling us produce intelligence that sparks change and health care innovation.
Health care innovation that works for you.
We have our sights set on better health for all—more affordable, more effective, and more equitable. In the ever-changing world of health care, the Evernorth Research Institute is tackling clients’ and patients’ biggest health care challenges to better understand and uncover opportunities for breakthrough improvements.
We give our clients and the industry useful, actionable information to make decisions that increase access to quality care and lower overall costs. Partner with us in our research to share in our discoveries and support tomorrow’s advancements.
Immune checkpoint inhibitor medications: A game-changer in cancer treatments
A new report from the Evernorth Research Institute offers insights that can help health plans optimize cancer care.
Our Latest Findings
A new report from the Evernorth Research Institute offers insights that can help health plans optimize cancer care.
New research suggests that a robust ecosystem inclusive of early identification, along with personalized care pathways with patient-to-provider matching, can result in improved outcomes.
This study describes the development of a binary classification machine learning model predicting 1-year mortality among Medicare Advantage plan members aged ≥65 years.
Improving access to regular cervical cancer screenings, especially for women in underserved communities, is key to reducing mortality rates.
Our data shows a higher prevalence of prescriptions filled for antiviral medications than in previous flu seasons.
Wear and tear conditions are the leading driver of musculoskeletal-related care and costs in the United States.
Investigating whether individuals newly diagnosed with a BHC who used outpatient behavioral health treatment incurred lower medical and pharmacy costs...
COVID-19 and other recent events have likely exacerbated stress and depression among teenagers in the United States.
This research investigates how income level and total out-of-pocket costs interact to influence the service utilization behavior of insured adult cancer patients with a comorbid mental or behavioral health diagnosis.
EGSDI identifies opportunities for proactive patient and community engagement for individuals diagnosed with type 2 diabetes...
There has been a steady decline in cancer deaths over the past couple of decades, driven by a significant decrease in the death rate for lung cancer...
This study explores how loneliness and other related factors may influence avoidable absenteeism and turnover intention.
Journal of Organizational Effectiveness: People and Performance
Recent studies have suggested that extended duration oral contraceptive pills (OCP), such as the 12-month duration, have a positive impact on...
After cigarette smoking among American adults hit an all-time low in 2018, new findings by Evernorth Research Institute suggests that smoking may be on the rise...
The COVID-19 pandemic has had a significant impact on healthcare delivery. Although others have documented the impact on new cancer...
This study describes changes in self-rated functional disability in a sample of plan members participating in a remotely delivered cognitive behavioral coaching program for commercial health plan members with low back pain.
The objective of this study was to describe national changes in utilization and associated costs of antidiabetic medications in the United States from...
Medication nonadherence in diabetes is well documented to be associated with inadequate glycemic control. Through remote blood...
Because of improved clinical outcomes, recent American Diabetes Association guidelines recommend the use of newer antidiabetic agents...
Given efforts to reduce opioid use, and because marijuana potentially offers a lower-risk alternative for treating chronic pain, there is interest in...
Transforming Health Care.
Our goal is to create more connected, compatible and convenient experiences for patients, providers and plan sponsors—and we believe transforming health care’s biggest challenges is the right place to start.
What does that transformation look like? For patients, it may be greater access and lower costs. For providers, it may be more transparency and greater collaboration across specialties. For plan sponsors, it may be reducing the administrative burden so many experience.
Transformation isn’t easy, but at the Evernorth Research Institute, we believe it is possible when it is purposeful and rooted in research.
Clinical Advisory Board
